These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1860068

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
    Whitehouse PJ, Kellar KJ.
    J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
    J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
    [Abstract] [Full Text] [Related]

  • 25. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains.
    Nordberg A, Adem A, Hardy J, Winblad B.
    Neurosci Lett; 1988 Apr 12; 86(3):317-21. PubMed ID: 3380323
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
    Sabbagh MN, Reid RT, Corey-Bloom J, Rao TS, Hansen LA, Alford M, Masliah E, Adem A, Lloyd GK, Thal LJ.
    J Neural Transm (Vienna); 1998 Apr 12; 105(6-7):709-17. PubMed ID: 9826113
    [Abstract] [Full Text] [Related]

  • 30. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW, Lai MK, Kirvell S, Francis PT, Esiri MM, Hope T, Chen CP, Wong PT.
    Neurobiol Aging; 2006 Sep 12; 27(9):1216-23. PubMed ID: 16129514
    [Abstract] [Full Text] [Related]

  • 31. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN, Shah F, Reid RT, Sue L, Connor DJ, Peterson LK, Beach TG.
    Arch Neurol; 2006 Dec 12; 63(12):1771-6. PubMed ID: 17172618
    [Abstract] [Full Text] [Related]

  • 32. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985 Dec 12; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S, Maskos U.
    Neuropharmacology; 2015 Sep 12; 96(Pt B):255-62. PubMed ID: 25514383
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissues.
    Rodŕiguez-Puertas R, Pascual J, Pazos A.
    Brain Res; 1996 Jul 22; 728(1):65-71. PubMed ID: 8864298
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
    Picciotto MR, Zoli M.
    Front Biosci; 2008 Jan 01; 13():492-504. PubMed ID: 17981563
    [Abstract] [Full Text] [Related]

  • 39. Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease.
    Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ.
    Neuropsychopharmacology; 1998 Dec 01; 19(6):472-80. PubMed ID: 9803423
    [Abstract] [Full Text] [Related]

  • 40. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
    Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nãsland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, Jaros E, Perry R, Ballard C, McKeith I, Court J.
    Eur J Pharmacol; 2000 Mar 30; 393(1-3):215-22. PubMed ID: 10771016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.